Plattsburgh,
NY, USA (July 17, 2014) - The Aerobika®
Oscillating Positive Expiratory Pressure (OPEP) Therapy System
marketed by Monaghan
Medical Corporation has earned Gold at the
Medical Design Excellence Awards (MDEA). MDEA is an International
Award recognizing groundbreaking products that save lives, improve
patient healthcare, change the face of medical technology, and
overcome design and engineering challenges. It is one of the medical
technology industry's highest honors.
The
Aerobika® Oscillating PEP device is a drug-free, easy
to use, hand-held device that helps people with COPD, Cystic Fibrosis
(CF) and other respiratory conditions to breathe easier and live
better. COPD (Chronic Obstructive Pulmonary Disease) is the fourth
leading cause of death globally and continues to grow in prevalence.
Clinical evaluations conducted at Robarts Research Institute (Western
University, London) demonstrated use of the device could
significantly reduce breathlessness and improve patient's quality of
life.
"When
the Aerobika® Oscillating PEP Therapy System was
created, the goal was to develop a product that addressed an unmet
need for patients suffering from serious respiratory conditions,
including COPD, CF, Bronchiectasis, Post Op and any patient with a
productive cough requiring a non - pharmaceutical method to assist
removing secretions from the lung. The innovation built into the
Aerobika® OPEP device delivers excellent effectiveness
while being very easy to use," states Dom Coppolo, Vice
President of Clinical Affairs at Monaghan Medical Corporation. "The
overall goal of the device is to ensure the patient can maintain
their treatments to control their symptoms, breathe easier, enjoy a
better quality of life and ultimately, stay out of the hospital."
The
award was announced at the MDEA Awards Ceremony held on Wednesday,
June 11, 2014 in New York City. Entries were evaluated by an
impartial panel of industry experts comprised of practicing doctors,
nurses, and technicians alongside industrial designers, engineers,
manufacturers, and human factors experts. The Aerobika®
Oscillating PEP device was deemed to excel in 5 evaluation criteria:
manufacturing and technological innovation; design and engineering
advancements; patient benefits; business benefits; and overall
improvement to healthcare industry.
The
Aerobika® Oscillating PEP device is available at many
leading hospitals across the United States and by prescription from a
physician. The Aerobika® Oscillating PEP device is
marketed by Monaghan Medical Corporation in the United States. For
more information about this story as well as image and video
downloads, please visit:
http://www.monaghanmed.com/news/aerobika-device-marketed-monaghan-medical-united-states-benefits-copd-patients-and-wins-gold-md.
About
Monaghan Medical Corporation
Monaghan
Medical Corporation (MMC), headquartered in Plattsburgh, New York
(USA), is a leader in the development, manufacture and/or marketing
of respiratory devices in the United States, such as the flagship
AeroChamber® Brand of Valved Holding Chamber (VHC) for
asthma patients. Its best-in-class respiratory management products
are developed and validated at its affiliate's world-renowned Aerosol
Lab. The respiratory management products it markets today and has
marketed in the past in the United States are the subject of peer
reviewed articles published in various medical journals, such as the
New England Journal of Medicine, CHEST.
Contact:
Karen
Teys
Director
of Marketing
Monaghan
Medical Corporation
800-343-9071
No comments:
Post a Comment